Related Experiment Video
Updated: Feb 5, 2026

Skeletal Muscle Gender Dimorphism from Proteomics
Published on: December 14, 2011
Gender Differences in Ischemic Cardiomyopathy
Laura Divoky1, Anbukarasi Maran1, Bhavadharini Ramu2
1Division of Cardiology, Department of Medicine, Medical University of South Carolina (MUSC), Strom Thurmond Gazes Building, 30 Courtenay Drive, BM 212, MSC 592, Charleston, SC, 29425, USA.
Insights
Cardiovascular disease (CVD) disproportionately affects women, leading to higher mortality from ischemic heart disease. This review highlights gender-specific challenges in diagnosing and treating ischemic cardiomyopathy in women, aiming to improve outcomes.
Area of Science:
- Cardiology
- Women's Health
- Medical Research
Background:
- Cardiovascular disease (CVD) is the leading global cause of death in women.
- Ischemic heart disease accounts for the majority of CVD deaths in women.
- Women with ischemic cardiomyopathy face significant morbidity and mortality.
Purpose of the Study:
- To review gender-specific differences in the burden, clinical presentation, and outcomes of ischemic cardiomyopathy in women.
- To identify challenges in the diagnosis and management of CVD in women.
- To highlight areas for future research to improve outcomes for women.
Main Methods:
- Literature review focusing on gender differences in ischemic cardiomyopathy.
- Analysis of current clinical practices and outcomes for women with CVD.
- Identification of knowledge gaps and research needs.
Main Results:
- Women experience poorer outcomes in ischemic cardiomyopathy due to various factors.
- Delays in presentation, diagnosis, and treatment contribute to adverse outcomes.
- Under-representation of women in clinical trials limits evidence-based guidelines.
Conclusions:
- Addressing gender-specific nuances is crucial for improving women's cardiovascular health.
- Further research is needed to understand and mitigate sex-based disparities in ischemic cardiomyopathy.
- Tailored diagnostic and management strategies are essential for better patient outcomes.
Purpose Of Review:
Cardiovascular disease remains the leading cause of death among women globally, majority of which are due to ischemic heart disease. Despite the recent advances in the overall management of CVD, there are unique challenges in the diagnosis and management of women as well as poorer outcomes.
Recent Findings:
Women with ischemic cardiomyopathy experience significant morbidity and mortality. Differences in underlying pathology, delays in presentation, diagnosis, and treatment as well as the under-representation of women in clinical trials contribute to these poor outcomes. In this review, we discuss the nuances of gender-specific differences in the burden, clinical presentation, and outcomes of ischemic cardiomyopathy in women, in addition to discussion of areas needing further research.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Socioemotional Experience and Gender Development
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification

